Cancer type | Obs | Exp | SIR | 95% CI |
All cancer | ||||
Men | 536 | 431 | 1.24 | 1.14–1.35 |
Women | 283 | 285 | 0.99 | 0.88–1.11 |
<40 years | 282 | 295 | 0.96 | 0.85–1.07 |
40–49 years | 357 | 282 | 1.27 | 1.14–1.40 |
≥50 years | 180 | 139 | 1.30 | 1.12–1.50 |
Liver | ||||
Men | 51 | 6.92 | 7.37 | 5.49–9.69 |
Women | 12 | 0.91 | 13.2 | 6.80–23.0 |
<40 years | 4 | 1.62 | 2.47 | 0.67–6.33 |
40–49 years | 26 | 3.96 | 6.57 | 4.29–9.63 |
≥50 years | 33 | 2.26 | 14.6 | 10.1–20.6 |
Trachea, bronchus and lung | ||||
Men | 82 | 19.8 | 4.15 | 3.32–5.11 |
Women | 28 | 7.59 | 3.69 | 2.45–5.33 |
<40 years | 15 | 4.11 | 3.65 | 2.04–6.02 |
40–49 years | 58 | 13.0 | 4.46 | 3.41–5.71 |
≥50 years | 37 | 10.2 | 3.61 | 2.57–4.90 |
Melanoma | ||||
Men | 64 | 91.2 | 0.70 | 0.54–0.89 |
Women | 37 | 48.7 | 0.76 | 0.54–1.03 |
<40 years | 48 | 71.6 | 0.67 | 0.50–0.88 |
40–49 years | 37 | 51.4 | 0.72 | 0.51–0.98 |
≥50 years | 16 | 16.9 | 0.95 | 0.56–1.49 |
Female breast | ||||
<40 years | 15 | 32.5 | 0.46 | 0.27–0.74 |
40–49 years | 27 | 54.3 | 0.48 | 0.32–0.69 |
≥50 years | 6 | 14.1 | 0.43 | 0.17–0.86 |
Cervical | ||||
<40 years | 21 | 11.0 | 1.90 | 1.20–2.84 |
40–49 years | 14 | 4.67 | 3.00 | 1.64–5.03 |
≥50 years | 2 | 0.63 | 3.19 | 0.39–11.5 |
Non-Hodgkin's lymphoma | ||||
Men | 62 | 38.1 | 1.63 | 1.26–2.07 |
Women | 13 | 11.5 | 1.13 | 0.62–1.86 |
<40 years | 25 | 20.9 | 1.20 | 0.79–1.73 |
40–49 years | 37 | 19.8 | 1.87 | 1.33–2.54 |
≥50 years | 13 | 8.94 | 1.46 | 0.78–2.49 |
Exp, expected number of cancers; Obs, observed number of cancers; SIR, standardised incidence ratio.